Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDAC·NASDAQ

$10.74

-0.19%
Financial ServicesShell Companies

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

At a Glance

Live Snapshot
Market Cap$235.29M
EPS0.3700
P/E Ratio29.03
Earnings Date05/15/2026

tdac

Net Cash Provided by Operating Activities

Last Annual Value

-608.39K

3-Year CAGR

-84%

5-Year CAGR

-44%

10-Year CAGR

-20%

Translational Development Acquisition Corp.

Translational Development Acquisition Corp. Competitors Analysis of Net Cash Provided by Operating Activities

TDAC · NASDAQ
CompanyNet Cash Provided by Operating Activities
CAGR 3Y
CAGR 5Y
CAGR 10Y
-608.39K
N/AN/AN/A 
52.58K
N/AN/AN/A
-600.84K
N/AN/AN/A
-903.13K
N/AN/AN/A
-890.18K
N/AN/AN/A
-464.69K
N/AN/AN/A
Translational Development Acquisition Corp.

Translational Development Acquisition Corp. Fair Value Envelope

TDAC · NASDAQ

Our analysis suggests that TDAC has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $10.74, this represents a potential HIDDEN relative to our calculated worth for Translational Development Acquisition Corp..

Intrinsic Value
Current Price: $10.74